ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0472

The Common Carotid Artery in the Ultrasound Evaluation of Giant Cell Arteritis

Charles Oshinsky1, Alison Bays1, Ingeborg Sacksen1, Elizabeth Jernberg2, R. Eugene zierler1 and Scott Pollock1, 1University of Washington, Seattle, WA, 2Virginia Mason, Seattle, WA

Meeting: ACR Convergence 2022

Keywords: giant cell arteritis, Ultrasound, Vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Vasculitis – Non-ANCA-Associated and Related Disorders Poster I: Giant Cell Arteritis

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Giant cell arteritis (GCA), the most common large vessel vasculitis, can cause irreversible vision loss if untreated. Vascular ultrasound has been used with greater frequency to facilitate rapid, accurate diagnosis of GCA. Though the temporal arteries and its branches and the axillary arteries are commonly included in the ultrasound evaluation of GCA, the role of carotid artery ultrasonography remains unclear. Though the carotid artery may be affected in GCA and show typical changes of vasculitis, the carotid artery is a common site of atherosclerosis, a potential confounder, and the additional diagnostic value of the carotid ultrasound exam remains undefined. This study sought to determine whether ultrasound of the common carotid artery in addition to the temporal and axillary arteries improved diagnostic accuracy compared to ultrasound of the temporal and axillary arteries alone.

Methods: A fast track clinic (FTC) was formed at the University of Washington in November 2017 to rapidly evaluate patients referred for concern for GCA. All subjects received a vascular ultrasound for GCA. A positive ultrasound had either a temporal artery halo sign, or increased intima-media thickness (IMT) of a large vessel. The IMT cutoff used for the common carotid artery was 1.5 mm.

Results: 177 subjects referred to the FTC from November, 2017 – June, 2022 for concern for suspected GCA completed an ultrasound for GCA that included carotid ultrasound. 65 subjects were diagnosed with GCA by their rheumatologist. 48 subjects had positive ultrasound findings. 12 subjects diagnosed with GCA had positive common carotid artery ultrasounds, and of those 12, two subjects had isolated common carotid artery involvement without temporal or axillary involvement. One of these two subjects presented with vision loss and had a positive temporal artery biopsy. The other subject was diagnosed in the setting of elevated inflammatory markers and high clinical suspicion for GCA. Of the 112 subjects not diagnosed with GCA, 8 subjects had positive common carotid artery ultrasounds, and five of these eight subjects had isolated common carotid artery involvement without temporal or axillary involvement. These 8 subjects with positive common carotid artery ultrasounds who were not diagnosed with GCA were deemed unlikely to have GCA by their treating rheumatologist based on clinical grounds. The sensitivity of ultrasound of the temporal, axillary and common carotid arteries was 64.6% and specificity 89.2%. When evaluating just the temporal and axillary arteries without the common carotids, sensitivity was 61.5% and specificity was 93.8%. The positive predictive value of a positive carotid artery ultrasound in isolation with negative temporal and axillary findings was 28.6%.

Conclusion: Though common carotid artery ultrasound may rarely identify GCA in patients with otherwise normal temporal and axillary arteries, the positive predictive value for GCA of isolated common carotid artery changes is poor and more likely to represent a false positive in our cohort. Our data suggest that it is reasonable to exclude the common carotid artery ultrasound from the standard vascular ultrasound protocol when evaluating for GCA.

Supporting image 1

Demographic features of patients referred to the FTC for concern for new onset GCA between 11/2017 and 6/2022 that had ultrasound for GCA performed including common carotid ultrasound

Supporting image 2

Vascular ultrasound features of patients referred to the FTC for new onset GCA between 11/2017 and 6/2022


Disclosures: C. Oshinsky, None; A. Bays, None; I. Sacksen, None; E. Jernberg, None; R. zierler, None; S. Pollock, None.

To cite this abstract in AMA style:

Oshinsky C, Bays A, Sacksen I, Jernberg E, zierler R, Pollock S. The Common Carotid Artery in the Ultrasound Evaluation of Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/the-common-carotid-artery-in-the-ultrasound-evaluation-of-giant-cell-arteritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-common-carotid-artery-in-the-ultrasound-evaluation-of-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology